| Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease P Hermann, B Appleby, JP Brandel, B Caughey, S Collins, ... The Lancet Neurology 20 (3), 235-246, 2021 | 260 | 2021 |
| The importance of ongoing international surveillance for Creutzfeldt–Jakob disease N Watson, JP Brandel, A Green, P Hermann, A Ladogana, T Lindsay, ... Nature Reviews Neurology 17 (6), 362-379, 2021 | 130 | 2021 |
| Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance P Hermann, M Laux, M Glatzel, J Matschke, T Knipper, S Goebel, J Treig, ... Neurology 91 (4), e331-e338, 2018 | 116 | 2018 |
| Rapidly progressive dementias—aetiologies, diagnosis and management P Hermann, I Zerr Nature Reviews Neurology 18 (6), 363-376, 2022 | 87 | 2022 |
| Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases I Zerr, M Schmitz, A Karch, A Villar-Piqué, E Kanata, E Golanska, ... Alzheimer's & Dementia 14 (6), 751-763, 2018 | 85 | 2018 |
| Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia F Llorens, P Hermann, A Villar-Piqué, D Diaz-Lucena, K Nägga, ... Nature communications 11 (1), 619, 2020 | 83 | 2020 |
| Age at onset in genetic prion disease and the design of preventive clinical trials EV Minikel, SM Vallabh, MC Orseth, JP Brandel, S Haïk, JL Laplanche, ... Neurology 93 (2), e125-e134, 2019 | 80 | 2019 |
| Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study H Saddiki, A Fayosse, E Cognat, S Sabia, S Engelborghs, D Wallon, ... PLoS medicine 17 (8), e1003289, 2020 | 68 | 2020 |
| CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD K Blennow, D Diaz-Lucena, H Zetterberg, A Villar-Pique, A Karch, E Vidal, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (8), 846-853, 2019 | 66 | 2019 |
| Plasma YKL-40 in the spectrum of neurodegenerative dementia A Villar-Piqué, M Schmitz, P Hermann, S Goebel, T Bunck, D Varges, ... Journal of neuroinflammation 16, 1-5, 2019 | 57 | 2019 |
| Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease N Watson, P Hermann, A Ladogana, A Denouel, S Baiardi, E Colaizzo, ... JAMA network open 5 (1), e2146319-e2146319, 2022 | 54 | 2022 |
| Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy M Schmitz, P Hermann, P Oikonomou, K Stoeck, E Ebert, T Poliakova, ... Neurobiology of aging 36 (9), 2597-2606, 2015 | 51 | 2015 |
| Diagnostic challenges in rapidly progressive dementia I Zerr, P Hermann Expert Review of Neurotherapeutics 18 (10), 761-772, 2018 | 43 | 2018 |
| Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: a multicenter prospective cohort study MK Georgakis, R Fang, M Düring, FA Wollenweber, FJ Bode, S Stösser, ... Alzheimer's & Dementia 19 (4), 1152-1163, 2023 | 41 | 2023 |
| Cerebrospinal fluid biomarkers of Alzheimer's disease show different but partially overlapping profile compared to vascular dementia F Llorens, M Schmitz, T Knipper, C Schmidt, P Lange, A Fischer, ... Frontiers in aging neuroscience 9, 289, 2017 | 41 | 2017 |
| Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease A Karch, P Hermann, C Ponto, M Schmitz, A Arora, S Zafar, F Llorens, ... Neurobiology of aging 36 (5), 1964-1968, 2015 | 40 | 2015 |
| A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease F Llorens, N Rübsamen, P Hermann, M Schmitz, A Villar‐Piqué, S Goebel, ... Alzheimer's & Dementia 16 (10), 1438-1447, 2020 | 39 | 2020 |
| Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease I Zerr, A Villar-Piqué, P Hermann, M Schmitz, D Varges, I Ferrer, J Riggert, ... Alzheimer's Research & Therapy 13, 1-15, 2021 | 35 | 2021 |
| CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease P Hermann, C Romero, C Schmidt, C Reis, I Zerr PLoS One 9 (8), e105000, 2014 | 33 | 2014 |
| Cerebrospinal fluid total and phosphorylated α-synuclein in patients with Creutzfeldt–Jakob disease and synucleinopathy M Schmitz, A Villar-Piqué, F Llorens, K Gmitterová, P Hermann, D Varges, ... Molecular Neurobiology 56, 3476-3483, 2019 | 30 | 2019 |
